Citation profile for T. Joseph Mattingly, II

T. Joseph Mattingly, II : Citation Profile

H index

i10 index

Citations

RESEARCH PRODUCTION:

Articles

RESEARCH ACTIVITY:

   5 years (2016 - 2021). See details.
   Cites by year: 1
   Journals where T. Joseph Mattingly, II has often published
   Relations with other researchers
   Recent citing documents: 1.    Total self citations: 5 (35.71 %)

MORE DETAILS IN:

EconPapers Author's homepage

ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pma2817
   Updated: 2024-11-08    RAS profile: 2023-11-19
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with T. Joseph Mattingly, II.

Is cited by:

Lorgelly, Paula (1)

Cites to:

Main data

Where T. Joseph Mattingly, II has published?

Journals with more than one article published	# docs
The Patient: Patient-Centered Outcomes Research	4
PharmacoEconomics	4

Recent works citing T. Joseph Mattingly, II (2024 and 2023)

Year	Title of citing document

Works by T. Joseph Mattingly, II:

Year	Title	Type	Cited
2019	Penicillin skin testing in methicillin-sensitive staphylococcus aureus bacteremia: A cost-effectiveness analysis In: PLOS ONE. [Full Text][Citation analysis]	article	0
2019	Implementing a Health Confidence Tool at Time of Discharge In: The Patient: Patient-Centered Outcomes Research. [Full Text][Citation analysis]	article	0
2019	What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism In: The Patient: Patient-Centered Outcomes Research. [Full Text][Citation analysis]	article	1
2021	The Importance of Collaboration in Pursuit of Patient-Centered Value Assessment In: The Patient: Patient-Centered Outcomes Research. [Full Text][Citation analysis]	article	1
2021	Patient Centeredness in Hepatitis C Direct-Acting Antiviral Treatment Delivery to People Who Inject Drugs: A Scoping Review In: The Patient: Patient-Centered Outcomes Research. [Full Text][Citation analysis]	article	0
2016	Publication of Cost-of-Illness Studies: Does Methodological Complexity Matter? In: PharmacoEconomics. [Full Text][Citation analysis]	article	1
2018	Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References? In: PharmacoEconomics. [Full Text][Citation analysis]	article	5
2020	Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis In: PharmacoEconomics. [Full Text][Citation analysis]	article	1
2020	Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review In: PharmacoEconomics. [Full Text][Citation analysis]	article	0
2021	Exploring Patient-Reported Costs Related to Hepatitis C on the Medical Crowdfunding Page GoFundMe® In: PharmacoEconomics - Open. [Full Text][Citation analysis]	article	0